Anti-GD2 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-GD2 antibody, covering 2018-03-30 to 2018-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy of Neuroblastoma Patients Using a Combination of Anti-GD2 and NK Cells [Phase 1, Phase 2]